Literature DB >> 15807277

[Expression and significance of mRNA for MIP-1alpha in cerebral tissue of newborn rat with hypoxic-ischemic brain damage].

Tao Zhang1, Ping Li.   

Abstract

OBJECTIVE: To observe the expression of mRNA for the MIP-1alpha in cerebral tissue after hypoxic-ischemic brain damage (HIBD) in newborn rat.
METHODS: The dynamic changes of expression of MIP-1alpha mRNA were studied using 7 d-old SD rat hypoxic-ischemic brain damage model and quantitative, real-time, fluorogenic PCR (TaqMan) assay.
RESULTS: Peaking transcription was shown at 6 hours after HIBD when MIP-1alpha mRNA level in the HI cerebral hemisphere was almost 10 times compared with that of control group. The mRNA level of 12 and 24 hours after HIBD was also greater than that of control group.
CONCLUSION: This appearance suggests that, as an inflammatory mediator, the MIP-1alpha transcription after HIBD may play important roles in the evolvement of brain damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807277

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  2 in total

1.  Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator.

Authors:  Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Zhao Lin; Neal Flomenberg; Anthony Howell; Richard G Pestell; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

2.  Prophylactic Chronic Zinc Administration Increases Neuroinflammation in a Hypoxia-Ischemia Model.

Authors:  Constantino Tomas-Sanchez; Victor Manuel Blanco-Alvarez; Juan Antonio Gonzalez-Barrios; Daniel Martinez-Fong; Guadalupe Garcia-Robles; Guadalupe Soto-Rodriguez; Eduardo Brambila; Maricela Torres-Soto; Alejandro Gonzalez-Vazquez; Ana Karina Aguilar-Peralta; José-Luis Garate-Morales; Luis-Angel Aguilar-Carrasco; Daniel I Limón; Jorge Cebada; Bertha Alicia Leon-Chavez
Journal:  J Immunol Res       Date:  2016-08-18       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.